0810010040: Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus Infection: A Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Subjects With Hepatitis C.
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2015
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Sep 2013 Treatment table added.
- 18 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.